Variant ID | 28363 |
---|---|
Entrez Gene ID | 11031 |
Gene | RAB31 (GeneCards) |
Location | hg19 18:9747094-9747094
hg38 18:9747097-9747097 |
Disease | Asymptomatic |
Method | Single cell Sequencing Cell cloning |
Mutation(HGVS format) | NC_000018.9:g.9747094 A>T (Genome Assembly: GRCh37) |
Exon or Intron | NA |
---|---|
Position in protein | NA |
Amino acid changes in protein | NA > NA |
Position in cDNA | NA |
Changes in cDNA | NA > NA |
mRNA accession | NA |
mRNA length | NA |
Reference length | 78077248 |
MAF in gnomAD genome (version 2.0.1) | 0 |
---|---|
EIGEN score | -0.1715 |
CADD Raw score (version 1.3) | 0.018872 (Deleterious) |
FATHMM raw prediction score | 0.08629 (Tolerated) |
Deleterious probability by DeFine | 0.1683 (Neutral) |
Entrez Gene ID | 11031 (NCBI Gene) |
---|---|
Official Gene Symbol | RAB31 (GeneCards) |
Number of variants in RAB31 in this database | 2 (view all the variants) |
Full name | RAB31, member RAS oncogene family |
Band | 18p11.22 |
Other IDs | Vega: OTTHUMG00000178513 OMIM: 605694 HGNC: HGNC:9771 Ensembl: ENSG00000168461 |
Other names | Rab22B |
Summary | Small GTP-binding proteins of the RAB family, such as RAB31, play essential roles in vesicle and granule targeting (Bao et al., 2002 [PubMed 11784320]).[supplied by OMIM, Jul 2009] |
Individual ID | 29217587.02 (view all the variants in this individual) |
---|---|
Pubmed ID | 29217587 |
Whose mosaic mutation | Normal |
Phenotype | 1 |
Disease | Asymptomatic |
OMIM ID |